Here we established an experimental model of HT-resistant metastatic disease and demonstrated that chronic suppression of ER led to reduced expression of ERα and conversely increased expression of autocrine IL6, selectively in CD133hi cells, driving the self-renewal capacity of these cells in HT-resistant metastases. Here, ESR1 is linked to metastatic neoplasm.